Artios in strong position to accelerate cancer programmes after Arix investment

December 19, 2018
Media coverage

Proactive Investors’ Andrew Scott sits down with Arix Bioscience Plc’s (LON:ARIX) investment director Jonathan Tobin and Niall Martin, chief executive of Artios Pharma to discuss the Series B financing.

Contact us

Reach out to us.